This investment in sterile drug product manufacturing enhances the existing service offering from Upperton, which provides formulation development across a broad range of dosage forms, clinical trial ...

This investment in sterile drug product manufacturing enhances the existing service offering from Upperton, which provides formulation development across a broad range of dosage forms, clinical trial ...

This investment in sterile drug product manufacturing enhances the existing service offering from Upperton, which provides formulation development across a broad range of dosage forms, clinical trial ...

Upperton Pharma Solutions, the contract development and manufacturing organisation (CDMO), has completed ... already develops and manufactures small molecule and biological, non-sterile, oral, nasal ...

U.K.-based CDMO Upperton Pharma Solutions expanded its production footprint with the completion of a new £7 million ($8.1 ...

As per DelveInsight estimates, North America is anticipated to dominate the global biologics drug substance manufacturing market during the forecast period. In the biologics type segment of the ...

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...

Additionally, the initiative said it was committed to “onshoring” drug ... sterile processing standards,” Arup Roy, Ph.D., Lilly’s senior vice president, technical services and ...

BEIJING, Jan 27 (Reuters) - China's January non-manufacturing activity grew but at a slower pace than in December, an official survey showed on Monday, suggesting policymakers need to introduce ...

A spokesperson said two separate investigations by the police led to discovery of importation of drugs and other illegal substances. In another investigation, a 33-year-old man was arrested after ...